The Journal of Globalization and Health recently published an interesting article entitled “Benefits of global partnerships to facilitate access to medicines:  a multi-country analysis of patients and patient outcomes in GIPAP.” The article concludes that The Glivec International Assistance Program (GIPAP) has a significant positive effect on patient access to important medicines for a life threatening condition such as Chronic Myeloid Leukemia.

It is encouraging that multinational pharmaceutical companies are continuing to invest significantly in research into neglected diseases.

A series of Case Studies for Global Health have recently been published by a partnership of leading global health organizations.  This publication highlights collaborations that are built and/or transactions that are entered into which address a global health concern.

{jcomments on}A recently released report by UNAIDS (2008 Report on the global AIDS epidemic) highlights encouraging news in the battle against HIV/AIDS -- the rate of global infections is slowing sharply.  The number of newly infected with HIV grew by 2.7 million in 2008,  bringing the world total to 33.4 million.